Gene therapy can effectively treat various diseases, but for some debilitating conditions like muscular dystrophies there is ...

StitchR, a new gene therapy technique, delivers large genes in two parts to treat muscular dystrophies by restoring critical proteins in animal models.

In relation to the acquisition of Vector’s Liquigas shares, our investigation found that the merged entity ... Zealand The project has been undertaken by University of Auckland Masters student Aman ...

Dr. Lahn's entrepreneurial spirit is equally impressive. In 2014, he founded VectorBuilder, a revolutionary online platform for vector design and ordering that has streamlined research workflows for ...

Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life ...

But there is a certain amount of interest around getting AI agents to use tools – mostly the kinds of tools you associate ...

StitchR makes it possible to deliver larger payloads with current vectors, expanding the list of diseases targetable by gene therapies.

VectorBuilder, a global leader in gene delivery solutions, proudly announces that its founder and chief scientist, Dr. Bruce Lahn, has been recognized on the 2024 Forbes China 100 Most Influential ...

Due to the fast-moving nature of AI and fear of missing out (FOMO), generative AI initiatives are often top-down driven, and enterprise leaders can tend to get overly excited abou ...

North Korea's latest launch of an intercontinental ballistic missile on Oct. 31 underscores the unusual aircraft's importance ...

QLSTM, a hybrid quantum-classical model, excels in stock price prediction, achieving a 50% RMSE reduction and 10% accuracy ...

Inovio Pharmaceuticals (NASDAQ: INO) Q3 2024 Earnings Call Nov 14, 2024, 4:30 p.m. ET ...